Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

ARRIVAL study group

Research output: Contribution to journal › Article › peer-review

150 Scopus citations

Fingerprint

Dive into the research topics of 'Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study'. Together they form a unique fingerprint.

Medicine & Life Sciences